Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Oct-Dec;6(4):169-171.
doi: 10.1016/j.ihjccr.2022.09.008. Epub 2022 Oct 7.

Mechanical prosthetic valve thrombosis after ChAdOx1-nCoV-19 vaccination: A case report

Affiliations
Case Reports

Mechanical prosthetic valve thrombosis after ChAdOx1-nCoV-19 vaccination: A case report

Akash Jain et al. IHJ Cardiovasc Case Rep. 2022 Oct-Dec.

Abstract

The ChAdOx1 nCoV-19 adenoviral vector-based vaccine was the first to be approved against COVID-19 in India. Vaccine induced thrombotic thrombocytopenia (VITT) is a rare but serious adverse effect of the ChAdOx1 nCoV-19 vaccine, causing widespread thrombosis and thrombocytopenia. A 22-year-old patient, who had undergone mechanical mitral valve replacement, presented to us one week after administration of 1st dose of the ChAdOx1 nCoV-19 Coronavirus vaccine with acute prosthetic heart valve thrombosis (PVT). Laboratory investigations revealed thrombocytopenia and high D-Dimer levels, suggestive of probable VITT. In this report, we highlight the importance of identification of VITT as a cause of PVT and discuss management options.

Keywords: Coronavirus; Heart valve diseases; Thrombosis; Vaccines.

PubMed Disclaimer

Conflict of interest statement

No conflict of interest.

Figures

Fig. 1
Fig. 1
Bedside Transthoracic echocardiogram with impaired mobility of the bileaflet mechanical prosthesis A) In systole, showing the immobile valve leaflets (white arrowhead) B) In diastole.
Fig. 2
Fig. 2
A) Increased mitral valve gradients B) Doppler of the tricuspid regurgitation jet showing elevated pulmonary artery systolic pressures.
Fig. 3
Fig. 3
A and B) Fluoroscopy showing impaired valve leaflet mobility (video 2).

References

    1. Ritchie H., Mathieu E., Rodés-Guirao L., et al. https://ourworldindata.org/covid-vaccinations Coronavirus Pandemic (COVID-19). Our World Data [Internet]. 2020 Mar 5 [cited 2022 Jul 28]; Available from:
    1. Voysey M., Costa Clemens S.A., Madhi S.A., et al. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. Lancet. 2021 Mar 6;397(10277):881–891. - PMC - PubMed
    1. Schultz N.H., Sørvoll I.H., Michelsen A.E., et al. Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination. N Engl J Med. 2021 Jun 3;384(22):2124–2130. - PMC - PubMed
    1. Greinacher A., Thiele T., Warkentin T.E., Weisser K., Kyrle P.A., Eichinger S. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med. 2021 Jun 3;384(22):2092–2101. - PMC - PubMed
    1. Tsilingiris D., Vallianou N.G., Karampela Ι., Dalamaga Μ. Vaccine induced thrombotic thrombocytopenia: the shady chapter of a success story. Metab Open. 2021 Sep 1;11 - PMC - PubMed

Publication types